About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Urology
›
top-articles
Department of Urology
236
(top 1%)
papers
7.5K
(top 1%)
citations
48
(top 1%)
h
-index
75
(top 1%)
g
-index
244
all documents
7.7K
doc citations
1.9K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Betaine Improves the PCR Amplification of GC-Rich DNA Sequences
Nucleic Acids Research
1997
440
2
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implications
International Journal of Cancer
2004
195
3
Laparoscopic Radical Prostatectomy
European Urology
2001
193
4
LAPAROSCOPIC RADICAL CYSTECTOMY WITH CONTINENT URINARY DIVERSION (RECTAL SIGMOID POUCH) PERFORMED COMPLETELY INTRACORPOREALLY: THE INITIAL 5 CASES
Journal of Urology
2001
190
5
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxina in a randomized, placebo‐controlled dose‐finding study in idiopathic overactive bladder
Neurourology and Urodynamics
2011
137
6
Laparoscopic Radical Prostatectomy - the Experience of the German Laparoscopic Working Group
European Urology
2006
131
7
Comparison of Eight Computer Programs for Receiver-Operating Characteristic Analysis
Clinical Chemistry
2003
122
8
Different mRNA and Protein Expression of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinases 1 in Benign and Malignant Prostate Tissue
European Urology
2002
121
9
Hepsin is Highly Over Expressed in and a New Candidate for a Prognostic Indicator in Prostate Cancer
Journal of Urology
2004
117
10
Evaluation of Magnetic Fluid Hyperthermia in a Standard Rat Model of Prostate Cancer
Journal of Endourology
2004
115
11
High-dose rate interstitial with external beam irradiation for localized prostate cancer – results of a prospective trial
Radiotherapy and Oncology
1998
113
12
Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5‐aminolaevulinic acid
BJU International
1999
110
13
Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood
Clinica Chimica Acta
2001
106
14
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma
Clinical Biochemistry
2007
104
15
Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer
Prostate
2000
100
16
Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue
Urology
2000
99
17
Genitourinary tuberculosis
Current Opinion in Urology
2001
99
18
Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer
2000
93
19
Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodies
Clinical Chemistry
1993
92
20
Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer
Cancer Letters
2004
92
21
Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach
American Journal of Transplantation
2020
91
22
Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate
Pediatric Nephrology
1999
88
23
The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia
Cancer
1997
85
24
Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues
British Journal of Cancer
2003
84
25
Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue
European Journal of Cancer
1999
81
26
Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma
Urology
2001
79
27
Molecular, cellular and developmental biology of urothelium as a basis of bladder regeneration
Differentiation
2005
74
28
Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer
Urology
2002
72
29
Management of Lymphoceles After Renal Transplantation: Laparoscopic Versus Open Drainage
Journal of Urology
2003
71
30
Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue
British Journal of Cancer
2001
70
31
Diagnosing Cancer in Vivo
Science
2001
69
32
An artificial neural network to predict the outcome of repeat prostate biopsies
Urology
2003
69
33
RATIO OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN IN SERUM CANNOT DISTINGUISH PATIENTS WITH PROSTATE CANCER FROM THOSE WITH CHRONIC INFLAMMATION OF THE PROSTATE
Journal of Urology
1998
68
34
Detection of Human Kallikrein 4 in Healthy and Cancerous Prostatic Tissues by Immunofluorometry and Immunohistochemistry
Clinical Chemistry
2002
67
35
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model
Oncogene
2002
66
36
Antioxidant Enzymes In Malignant Prostate Cell Lines and In Primary Cultured Prostatic Cells
Free Radical Biology and Medicine
1997
65
37
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues
Prostate
2002
64
38
Botulinum neurotoxin type A in urology: Antibodies as a cause of therapy failure
International Journal of Urology
2008
64
39
Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury
Transplantation
2003
62
40
Analytical performance and clinical validity of two free prostate-specific antigen assays compared
Clinical Chemistry
1996
61
41
Analytical Aspects Regarding the Measurement of Metalloproteinases and Their Inhibitors in Blood
Clinical Biochemistry
1997
59
42
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues
Prostate
2003
59
43
Developmental changes of antioxidant enzymes in kidney and liver from rats
Free Radical Biology and Medicine
1996
57
44
Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer
1997
57
45
Factors influencing the ratio of free to total prostate-specific antigen in serum
1997
57
46
LAPAROSCOPIC LIVE DONOR RIGHT NEPHRECTOMY: A NEW TECHNIQUE WITH PRESERVATION OF VASCULAR LENGTH
Journal of Urology
2002
57
47
Molecular Cloning of a Novel Human Acid Phosphatase Gene (ACPT) That Is Highly Expressed in the Testis
Genomics
2001
53
48
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma
International Journal of Cancer
2000
52
49
Laparoscopic anatrophic nephrolithotomy
Scandinavian Journal of Urology and Nephrology
2004
51
50
LAPAROSCOPIC RADICAL CYSTECTOMY WITH CONTINENT URINARY DIVERSION (RECTAL SIGMOID POUCH) PERFORMED COMPLETELY INTRACORPOREALLY:
Journal of Urology
2001
50
site/software ©
exaly
; All materials licenced under
CC by-SA
.